Aarti Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0LRU01027
  • NSEID: AARTIPHARM
  • BSEID: 543748
INR
821.45
136.9 (20.0%)
BSENSE

Aug 10

BSE+NSE Vol: 33.0 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003784,
    "name": "Aarti Pharma",
    "stock_name": "Aarti Pharma",
    "full_name": "Aarti Pharmalabs Ltd",
    "name_url": "stocks-analysis/aarti-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "821.45",
    "chg": 136.9,
    "chgp": "20.0%",
    "dir": 1,
    "prev_price": "684.55",
    "mcapval": "7,449.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543748,
    "symbol": "AARTIPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0LRU01027",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "33.0 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/aarti-pharma-1003784-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Aarti Pharmalabs Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-pharmalabs-ltd-is-rated-sell-by-marketsmojo-3998737",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AartiPharmalabs_mojoScore_3998737.png",
        "date": "2026-05-19 10:11:09",
        "description": "Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 May 2026, providing investors with the most recent and relevant data to assess the company’s outlook."
      }
    ],
    "total": 15,
    "sid": "1003784",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/aarti-pharmalabs-1003784"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "09-Aug-2026",
      "details": "Newspaper Publication on Financial Results",
      "source": "BSE"
    },
    {
      "caption": "Approval Of Unaudited Financial Results (Standalone And Consolidated)For The Quarter Ended June 30 2026",
      "datetime": "07-Aug-2026",
      "details": "Approval of Unaudited Financial Results (Standalone and Consolidated) for the Quarter Ended June 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
      "datetime": "07-Aug-2026",
      "details": "Disclosure as enclosed",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aarti Pharmalabs Ltd has declared <strong>30%</strong> dividend, ex-date: 16 Feb 26",
          "dt": "2026-02-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

09-Aug-2026 | Source : BSE

Newspaper Publication on Financial Results

Approval Of Unaudited Financial Results (Standalone And Consolidated)For The Quarter Ended June 30 2026

07-Aug-2026 | Source : BSE

Approval of Unaudited Financial Results (Standalone and Consolidated) for the Quarter Ended June 30 2026

Announcement under Regulation 30 (LODR)-Change in Directorate

07-Aug-2026 | Source : BSE

Disclosure as enclosed

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Aarti Pharmalabs Ltd has declared 30% dividend, ex-date: 16 Feb 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available